Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin vs oral hypoglycemic drugs before THA/TKA in patients with type 2 diabetes mellitus
ChiCTR-IPR-16008228Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin in type 2 diabetes mellitus (T2DM), hip osteoarthritis and knee osteoarthritis (OA) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: fasting blood-glucose and postprandial blood sugar. Started Apr 2016; status: recruiting.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)hip osteoarthritisknee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-16008228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008228.